Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure.
Publication Type:Journal Article
Source:ACS Med Chem Lett, Volume 8, Issue 3, p.316-320 (2017)
<p>Apoptosis signal-regulating kinase 1 (ASK1/MAP3K) is a mitogen-activated protein kinase family member shown to contribute to acute ischemia/reperfusion injury. Using structure-based drug design, deconstruction, and reoptimization of a known ASK1 inhibitor, a lead compound was identified. This compound displayed robust MAP3K pathway inhibition and reduction of infarct size in an isolated perfused heart model of cardiac injury.</p>